Primary Biliary Cirrhosis Treatment Market By Drug Type 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Primary Biliary Cirrhosis (Pbc) Treatment Market
Primary Biliary Cirrhosis (Pbc) Treatment Market By Drug Type (Ursodeoxycholic Acid, Obeticholic Acid, Corticosteroids, Methotrexate); By Surgery (Liver Transplant); By Diagnosis Test (Blood Test, Imaging, Liver Biopsy) & By Geography - Forecast(2018 - 2023)
Report Code : HCR 0256
Updated Date: 15 May, 2018  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Primary Biliary Cirrhosis Treatment Market Overview
   1.1. Introduction
   1.2. Classification
2. Executive Summary
3. PBC Treatment Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. Patent Analysis
      3.2.3. Financials of Key Players
4. PBC Treatment Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Suppliers Power
      4.4.2. Bargaining Power of Buyer
      4.4.3. Threat from New Entrants
      4.4.4. Threats from Substitutes   
      4.4.5. Degree of Competition
5. PBC Treatment Market – Strategic Analysis
   5.1. Supply Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
6. PBC Drugs Market– By Type
   6.1. Ursodeoxycholic Acid
   6.2. Obeticholic Acid
   6.3. Corticosteroids
   6.4. Methotrexate
   6.5. Others
7. PBC Surgery Market
   7.1. Introduction
   7.2. Liver Transplant Services
8. PBC Diagnosis Tests Market- By Type
   8.1. Blood Tests
      8.1.1. AMA Test
      8.1.2. ALT Test
      8.1.3. AST Test
      8.1.4. ALP Test
      8.1.5. Others
   8.2. Imaging Tests
      8.2.1. Ultrasound
      8.2.2. CT Scan
      8.2.3. MRI
      8.2.4. Others
   8.3. Liver Biopsy
9. PBC Treatment Market-Geographic Analysis
   9.1. Introduction
   9.2. North America
      9.2.1.  U.S.
      9.2.2.  Canada
      9.2.3.  Mexico
   9.3. Europe
      9.3.1.  U.K.
      9.3.2.  Germany
      9.3.3.  France
      9.3.4.  Russia
      9.3.5.  Rest of Europe
   9.4. APAC
      9.4.1.  China
      9.4.2.  Japan
      9.4.3.  India
      9.4.4.  Rest of APAC
   9.5. RoW
      9.5.1.  South America
      9.5.2.  Middle East
      9.5.3. Africa
10. Market Entropy
11. Company Profiles (Overview, Financials, Developments and Product Portfolio)     

   11.1. Mankind Pharmaceuticals Pvt. Ltd.
   11.2. Solvay Pharma India Pvt Ltd
   11.3. Zydus Pharmaceuticals
   11.4. Mylan N.V.
   11.5. Hexal AG
   11.6. Sanofi S.A.
   11.7. Sigma Pharmaceuticals Ltd
   11.8. Intercept Pharmaceuticals, Inc.
   11.9. Teva Pharmaceuticals Industries Ltd
   11.10. FF Pharma
12. Appendix
   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
Primary biliary cirrhosis, also known as primary biliary cholangitis (PBC), is an autoimmune disease of the liver which is relatively rare as compared to other gastro diseases. The advanced stage of PBC is considered as cirrhosis. Identification, diagnosis and treatment differ based on the severity of PBC and patients’ condition. Several diagnosis tests are recommended including blood tests, imaging tests and liver biopsy which further encompass several test methods. The treatment includes medication approach as well as surgical approach. Medical approach includes employment of approved drugs individually or in combination including Ursodeoxycholic Acid, Corticosteroids and Methotrexate which are marketed under different brand names. Obeticholic Acid, new drug is under clinical trials and is expected to be launched in the near future.

The growth of this market is primarily attributed to increasing availability of treatment services and drugs. In addition, to drugs, liver transplantation is performed which completely prevents PBC. Establishment of diagnosis and treatment standards in the recent years boosts the overall service experience as well as treatment outcomes which propels the market growth. Driven by the aforementioned factors, this market is set to reach $XX billion by 2021, growing at a CAGR of XX% during 2016-2021.

Primary Biliary Cirrhosis Market

North America held a major share of XX% in the PBC drugs market, followed by Europe and APAC. Commercialization of new drugs and expanding specialized services for liver in India and China is set to boost the market revenue in APAC region.

The key players in the PBC Drugs market include:
  • Sanofi S.A.
  • Intercept Pharmaceuticals, Inc.
  • Mylan N.V.
  • Mankind Pharmaceuticals Pvt. Ltd.

The estimates and forecasts have been derived based on various inputs from primary and secondary sources. Secondary sources such as articles, whitepapers, journals and other has helped to deliver an extensive analysis in this report. Insights related to various regulatory frameworks and clinical studies have been collected from publications by health regulatory agencies. To enhance the accuracy of the estimates, the data has been validated by conducting interviews with industry experts. This report on the PBC treatment market identifies many such insights, new product developments, besides providing a detailed analysis of the key drug companies, treatment service providers and growth potential of the market.
List of Tables:

Table 1: Primary Biliary Cirrhosis (Pbc) Treatment Market Overview 2017-2023
Table 2: Primary Biliary Cirrhosis (Pbc) Treatment Market Leader Analysis 2017-2018 (US$)
Table 3: Primary Biliary Cirrhosis (Pbc) Treatment Market Product Analysis 2017-2018 (US$)
Table 4: Primary Biliary Cirrhosis (Pbc) Treatment Market End User Analysis 2017-2018 (US$)
Table 5: Primary Biliary Cirrhosis (Pbc) Treatment Market Patent Analysis 2013-2018* (US$)
Table 6: Primary Biliary Cirrhosis (Pbc) Treatment Market Financial Analysis 2017-2018 (US$)
Table 7: Primary Biliary Cirrhosis (Pbc) Treatment Market Driver Analysis 2017-2018 (US$)
Table 8: Primary Biliary Cirrhosis (Pbc) Treatment Market Challenges Analysis 2017-2018 (US$)
Table 9: Primary Biliary Cirrhosis (Pbc) Treatment Market Constraint Analysis 2017-2018 (US$)
Table 10: Primary Biliary Cirrhosis (Pbc) Treatment Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table 11: Primary Biliary Cirrhosis (Pbc) Treatment Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table 12: Primary Biliary Cirrhosis (Pbc) Treatment Market Threat of Substitutes Analysis 2017-2018 (US$)
Table 13: Primary Biliary Cirrhosis (Pbc) Treatment Market Threat of New Entrants Analysis 2017-2018 (US$)
Table 14: Primary Biliary Cirrhosis (Pbc) Treatment Market Degree of Competition Analysis 2017-2018 (US$)
Table 15: Primary Biliary Cirrhosis (Pbc) Treatment Market Value Chain Analysis 2017-2018 (US$)
Table 16: Primary Biliary Cirrhosis (Pbc) Treatment Market Pricing Analysis 2018-2023 (US$)
Table 17: Primary Biliary Cirrhosis (Pbc) Treatment Market Opportunities Analysis 2018-2023 (US$)
Table 18: Primary Biliary Cirrhosis (Pbc) Treatment Market Product Life Cycle Analysis 2018-2023 (US$)
Table 19: Primary Biliary Cirrhosis (Pbc) Treatment Market Supplier Analysis 2017-2018 (US$)
Table 20: Primary Biliary Cirrhosis (Pbc) Treatment Market Distributor Analysis 2017-2018 (US$)
Table 21: Primary Biliary Cirrhosis (Pbc) Treatment Market Trend Analysis 2017-2018 (US$)
Table 22: Primary Biliary Cirrhosis (Pbc) Treatment Market Size 2017 (US$)
Table 23: Primary Biliary Cirrhosis (Pbc) Treatment Market Forecast Analysis 2018-2023 (US$)
Table 24: Primary Biliary Cirrhosis (Pbc) Treatment Market Sales Forecast Analysis 2018-2023 (Units)
Table 25: Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 26: Primary Biliary Cirrhosis (Pbc) Treatment Market By Type, Revenue & Volume, By Ursodeoxycholic Acid, 2018-2023 ($)
Table 27: Primary Biliary Cirrhosis (Pbc) Treatment Market By Type, Revenue & Volume, By Obeticholic Acid, 2018-2023 ($)
Table 28: Primary Biliary Cirrhosis (Pbc) Treatment Market By Type, Revenue & Volume, By Corticosteroids, 2018-2023 ($)
Table 29: Primary Biliary Cirrhosis (Pbc) Treatment Market By Type, Revenue & Volume, By Methotrexate, 2018-2023 ($)
Table 30: Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 31: Primary Biliary Cirrhosis (Pbc) Treatment Market By Type, Revenue & Volume, By Blood Tests, 2018-2023 ($)
Table 32: Primary Biliary Cirrhosis (Pbc) Treatment Market By Type, Revenue & Volume, By Imaging Tests, 2018-2023 ($)
Table 33: Primary Biliary Cirrhosis (Pbc) Treatment Market By Type, Revenue & Volume, By Liver Biopsy, 2018-2023 ($)
Table 34: North America Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 35: North America Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 36: South america Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 37: South america Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 38: Europe Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 39: Europe Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 40: APAC Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 41: APAC Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 42: Middle East & Africa Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 43: Middle East & Africa Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 44: Russia Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 45: Russia Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 46: Israel Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 47: Israel Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume, By Type, 2018-2023 ($)
Table 48: Top Companies 2017 (US$)Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume
Table 49: Product Launch 2017-2018Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume
Table 50: Mergers & Acquistions 2017-2018Primary Biliary Cirrhosis (Pbc) Treatment Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Primary Biliary Cirrhosis (Pbc) Treatment Market 2017-2023
Figure 2: Market Share Analysis for Primary Biliary Cirrhosis (Pbc) Treatment Market 2017 (US$)
Figure 3: Product Comparison in Primary Biliary Cirrhosis (Pbc) Treatment Market 2017-2018 (US$)
Figure 4: End User Profile for Primary Biliary Cirrhosis (Pbc) Treatment Market 2017-2018 (US$)
Figure 5: Patent Application and Grant in Primary Biliary Cirrhosis (Pbc) Treatment Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Primary Biliary Cirrhosis (Pbc) Treatment Market 2017-2018 (US$)
Figure 7: Market Entry Strategy in Primary Biliary Cirrhosis (Pbc) Treatment Market 2017-2018
Figure 8: Ecosystem Analysis in Primary Biliary Cirrhosis (Pbc) Treatment Market 2017
Figure 9: Average Selling Price in Primary Biliary Cirrhosis (Pbc) Treatment Market 2017-2023
Figure 10: Top Opportunites in Primary Biliary Cirrhosis (Pbc) Treatment Market 2017-2018
Figure 11: Market Life Cycle Analysis in Primary Biliary Cirrhosis (Pbc) Treatment Market Market Life Cycle Analysis in 3D Printing
Figure 12: GlobalBy TypePrimary Biliary Cirrhosis (Pbc) Treatment Market Revenue, 2018-2023 ($)
Figure 13: GlobalBy TypePrimary Biliary Cirrhosis (Pbc) Treatment Market Revenue, 2018-2023 ($)
Figure 14: Global Primary Biliary Cirrhosis (Pbc) Treatment Market - By Geography
Figure 15: Global Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 16: Global Primary Biliary Cirrhosis (Pbc) Treatment Market CAGR, By Geography, 2018-2023 (%)
Figure 17: North America Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 18: US Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 19: US GDP and Population, 2017-2018 ($)
Figure 20: US GDP – Composition of 2017, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2017-2018 ($)
Figure 22: Canada Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 23: Canada GDP and Population, 2017-2018 ($)
Figure 24: Canada GDP – Composition of 2017, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 26: Mexico Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 27: Mexico GDP and Population, 2017-2018 ($)
Figure 28: Mexico GDP – Composition of 2017, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 30: South America Primary Biliary Cirrhosis (Pbc) Treatment Market South America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 31: Brazil Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 32: Brazil GDP and Population, 2017-2018 ($)
Figure 33: Brazil GDP – Composition of 2017, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 35: Venezuela Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 36: Venezuela GDP and Population, 2017-2018 ($)
Figure 37: Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 39: Argentina Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 40: Argentina GDP and Population, 2017-2018 ($)
Figure 41: Argentina GDP – Composition of 2017, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 43: Ecuador Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 44: Ecuador GDP and Population, 2017-2018 ($)
Figure 45: Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 47: Peru Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 48: Peru GDP and Population, 2017-2018 ($)
Figure 49: Peru GDP – Composition of 2017, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 51: Colombia Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 52: Colombia GDP and Population, 2017-2018 ($)
Figure 53: Colombia GDP – Composition of 2017, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 55: Costa Rica Primary Biliary Cirrhosis (Pbc) Treatment Market Costa Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 56: Costa Rica GDP and Population, 2017-2018 ($)
Figure 57: Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 59: Europe Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 60: U.K Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 61: U.K GDP and Population, 2017-2018 ($)
Figure 62: U.K GDP – Composition of 2017, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 64: Germany Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 65: Germany GDP and Population, 2017-2018 ($)
Figure 66: Germany GDP – Composition of 2017, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 68: Italy Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 69: Italy GDP and Population, 2017-2018 ($)
Figure 70: Italy GDP – Composition of 2017, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 72: France Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 73: France GDP and Population, 2017-2018 ($)
Figure 74: France GDP – Composition of 2017, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2017-2018 ($)
Figure 76: Netherlands Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 77: Netherlands GDP and Population, 2017-2018 ($)
Figure 78: Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 80: Belgium Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 81: Belgium GDP and Population, 2017-2018 ($)
Figure 82: Belgium GDP – Composition of 2017, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 84: Spain Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 85: Spain GDP and Population, 2017-2018 ($)
Figure 86: Spain GDP – Composition of 2017, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 88: Denmark Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 89: Denmark GDP and Population, 2017-2018 ($)
Figure 90: Denmark GDP – Composition of 2017, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 92: APAC Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 93: China Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023
Figure 94: China GDP and Population, 2017-2018 ($)
Figure 95: China GDP – Composition of 2017, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2017-2018 ($)Primary Biliary Cirrhosis (Pbc) Treatment Market China Export and Import Value & Volume, 2017-2018 ($)
Figure 97: Australia Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 98: Australia GDP and Population, 2017-2018 ($)
Figure 99: Australia GDP – Composition of 2017, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 101: South Korea Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 102: South Korea GDP and Population, 2017-2018 ($)
Figure 103: South Korea GDP – Composition of 2017, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 105: India Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 106: India GDP and Population, 2017-2018 ($)
Figure 107: India GDP – Composition of 2017, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2017-2018 ($)
Figure 109: Taiwan Primary Biliary Cirrhosis (Pbc) Treatment Market Taiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 110: Taiwan GDP and Population, 2017-2018 ($)
Figure 111: Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 113: Malaysia Primary Biliary Cirrhosis (Pbc) Treatment Market Malaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 114: Malaysia GDP and Population, 2017-2018 ($)
Figure 115: Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 117: Hong Kong Primary Biliary Cirrhosis (Pbc) Treatment Market Hong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 118: Hong Kong GDP and Population, 2017-2018 ($)
Figure 119: Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 121: Middle East & Africa Primary Biliary Cirrhosis (Pbc) Treatment Market Middle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 122: Russia Primary Biliary Cirrhosis (Pbc) Treatment Market Russia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 123: Russia GDP and Population, 2017-2018 ($)
Figure 124: Russia GDP – Composition of 2017, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 126: Israel Primary Biliary Cirrhosis (Pbc) Treatment Market Value & Volume, 2018-2023 ($)
Figure 127: Israel GDP and Population, 2017-2018 ($)
Figure 128: Israel GDP – Composition of 2017, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 130: Entropy Share, By Strategies, 2017-2018* (%)Primary Biliary Cirrhosis (Pbc) Treatment Market
Figure 131: Developments, 2017-2018*Primary Biliary Cirrhosis (Pbc) Treatment Market
Figure 132: Company 1 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 133: Company 1 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 134: Company 1 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 135: Company 2 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 136: Company 2 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 137: Company 2 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 138: Company 3 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 139: Company 3 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 140: Company 3 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 141: Company 4 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 142: Company 4 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 143: Company 4 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 144: Company 5 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 145: Company 5 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 146: Company 5 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 147: Company 6 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 148: Company 6 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 149: Company 6 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 150: Company 7 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 151: Company 7 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 152: Company 7 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 153: Company 8 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 154: Company 8 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 155: Company 8 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 156: Company 9 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 157: Company 9 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 158: Company 9 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 159: Company 10 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 160: Company 10 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 161: Company 10 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 162: Company 11 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 163: Company 11 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 164: Company 11 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 165: Company 12 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 166: Company 12 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 167: Company 12 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 168: Company 13 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 169: Company 13 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 170: Company 13 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 171: Company 14 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 172: Company 14 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 173: Company 14 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2017 (%)
Figure 174: Company 15 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue, By Years, 2017-2018* ($)
Figure 175: Company 15 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Revenue Share, By Business segments, 2017 (%)
Figure 176: Company 15 Primary Biliary Cirrhosis (Pbc) Treatment Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll